Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024;22(1):65-71.
doi: 10.2174/011570162X273667231213061301.

Bone Metabolism in Men who Live with HIV Aged 50 years and Over: Impact of Infection Duration

Affiliations

Bone Metabolism in Men who Live with HIV Aged 50 years and Over: Impact of Infection Duration

Bilge Caglar et al. Curr HIV Res. 2024.

Abstract

Background: Early diagnosis and effective antiretroviral therapy (ART) lead to similar life expectancy in people living with HIV (PLWH) compared to the general population. This population faces problems such as decreased bone mineral density (BMD) and increased fracture risk. The aim of this study was to determine the prevalence of osteoporosis in men aged 50 years and over who were PLWH and to determine risk factors and changes in bone metabolism with bone turnover markers.

Methods: 79 male PLWH aged 50 years and over were followed up in our outpatient clinic between May 2021 and October 2021. The patients' demographic, clinical, laboratory, and DEXA data were analyzed. Serum levels of bone turnover markers were measured.

Results: The prevalence of osteopenia, osteoporosis, and normal BMD was found to be 55.7%, 13.9%, and 30.4%, respectively. A correlation was found between low BMD and low body mass index, elapsed time since diagnosis of HIV infection, high rate of use of ART, and long usage time of tenofovir disoproxil fumarate + protease inhibitor. A one-year increase in HIV infection duration was associated with an increased risk of low BMD by 1.246.

Conclusion: Compared to studies conducted on the general population, the prevalence of osteoporosis in male PLWH aged 50 years and older was two times higher. The limited effect of the duration of ART use on low BMD may be due to the patients' histories of replacement therapy. Therefore, to eliminate the negative effects of ART on BMD, it may be beneficial to start replacement therapy when necessary.

Keywords: Bone mineral density; HIV; antiretroviral treatment; male over 50 years old; osteopenia.; osteoporosis.

PubMed Disclaimer

References

    1. Mallon P.W.G.; Aging with HIV. Curr Opin HIV AIDS 2014,9(4),428-435 - DOI - PubMed
    1. de Almeida L.L.; Ilha T.A.S.H.; de Carvalho J.A.M.; Stein C.; Caeran G.; Comim F.V.; Moresco R.N.; Haygert C.J.P.; Compston J.E.; Premaor M.O.; Sarcopenia and its association with vertebral fractures in people living with HIV. Calcif Tissue Int 2020,107(3),249-256 - DOI - PubMed
    1. Tükenmez-Tigen E.; Korten V.; Effects of HIV infection and antiretroviral treatment on the development of osteopenia. Klimik Derg 2012,25(2),51-57
    1. Hoy J.; Bone disease in HIV: Recommendations for screening and management in the older patient. Drugs Aging 2015,32(7),549-558 - DOI - PubMed
    1. Turkish endocrinology and metabolism association. osteoporosis and metabolic bone diseases diagnosis and treatment guide. Available from: https://temd.org.tr/kilavuzlar

Substances